Company · CIK 0001125345 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
MACROGENICS INC · MGNX
Insider activity reported against this company. All insider holders · Files at: PRVB. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 SForm 4 → | Aug 20, 6:19 pm EDT | Jeffrey Stuart PetersSenior VP, GC, and Secretary | 31,105 | $4.15 | $129,086 | 0 | −100% | 10b5-1 |
| Aug 17, 2026 MForm 4 → | Aug 18, 4:19 pm EDT | Ezio BonviniSr VP, Research & CSO | 40,000 | $2.60 | $104,000 | 185,799 | — | |
| Feb 6, 2019 SForm 4 → | Feb 8, 5:41 pm EST | Matthew K FustDirector | 6,924 | $29.38 | $203,427 | 500 | −93.3% | plan? |
| Feb 6, 2019 MForm 4 → | Feb 8, 5:41 pm EST | Matthew K FustDirector | 6,924 | $20.15 | $139,519 | 7,424 | — | plan? |
| Feb 6, 2019 SForm 4 → | Feb 8, 5:40 pm EST | Jeffrey Stuart PetersGeneral Counsel | 68 | $30.00 | $2,040 | 202 | −25.2% | plan? |
| Feb 6, 2019 SForm 4 → | Feb 8, 5:40 pm EST | Thomas SpitznagelSr VP, BPD & Manufacturing | 1,770 | $30.00 | $53,100 | 0 | −100% | plan? |
| Feb 6, 2019 MForm 4 → | Feb 8, 5:40 pm EST | Thomas SpitznagelSr VP, BPD & Manufacturing | 1,770 | $7.51 | $13,293 | 1,770 | — | plan? |
| Jan 28, 2019 MForm 4 → | Jan 28, 4:12 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 6,000 | $0.94 | $5,640 | 28,309 | — | plan? |
| Jan 24, 2019 MForm 4 → | Jan 28, 4:10 pm EST | James KarrelsSVP, CFO and Secretary | 7,326 | $0.94 | $6,886 | 135,487 | — | plan? |
| Jan 8, 2019 MForm 4 → | Jan 10, 3:58 pm EST | James KarrelsSVP, CFO and Secretary | 5,314 | $0.94 | $4,995 | 128,161 | — | plan? |
| Jan 3, 2019 MForm 4 → | Jan 4, 4:29 pm EST | Scott KoenigPresident and CEO, Director | 39,897 | $0.94 | $37,503 | 213,060 | — | plan? |
| Dec 18, 2018 MForm 4 → | Dec 20, 4:04 pm EST | James KarrelsSVP, CFO and Secretary | 5,000 | $0.94 | $4,700 | 122,847 | — | plan? |
| Dec 12, 2018 MForm 4 → | Dec 13, 4:39 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 5,000 | $0.94 | $4,700 | 22,309 | — | plan? |
| Nov 27, 2018 MForm 4 → | Nov 27, 4:44 pm EST | James KarrelsSVP, CFO and Secretary | 3,000 | $0.94 | $2,820 | 117,847 | — | plan? |
| Nov 13, 2018 MForm 4 → | Nov 14, 4:48 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 4,000 | $0.94 | $3,760 | 16,100 | — | plan? |
| Nov 13, 2018 MForm 4 → | Nov 14, 4:32 pm EST | Scott KoenigPresident and CEO, Director | 40,000 | $0.94 | $37,600 | 173,163 | — | plan? |
| Oct 22, 2018 MForm 4 → | Oct 23, 12:32 pm EDT | Eric Blasius RisserSr VP & Chief Business Officer | 3,000 | $0.94 | $2,820 | 12,100 | — | plan? |
| Mar 12, 2018 SForm 4 → | Mar 14, 5:12 pm EDT | Eric Blasius RisserSr VP & Chief Business Officer | 1,000 | $31.08 | $31,080 | 9,100 | −9.90% | plan? |
| Mar 12, 2018 MForm 4 → | Mar 14, 5:12 pm EDT | Eric Blasius RisserSr VP & Chief Business Officer | 1,000 | $0.94 | $940 | 10,100 | — | plan? |
| Mar 5, 2018 SForm 4 → | Mar 7, 6:46 pm EST | James KarrelsSVP, CFO and Secretary | 5,000 | $31.00 | $155,000 | 114,847 | −4.17% | plan? |
| Mar 2, 2018 SForm 4 → | Mar 6, 5:24 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 4,000 | $30.00 | $120,000 | 9,100 | −30.5% | plan? |
| Mar 2, 2018 MForm 4 → | Mar 6, 5:24 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 4,000 | $0.94 | $3,760 | 13,100 | — | plan? |
| Feb 28, 2018 SForm 4 → | Mar 1, 5:24 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 1,000 | $25.01 | $25,005 | 9,100 | −9.90% | plan? |
| Feb 28, 2018 MForm 4 → | Mar 1, 5:24 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 1,000 | $0.94 | $940 | 10,100 | — | plan? |
| Feb 28, 2018 SForm 4 → | Mar 1, 5:24 pm EST | Lynn CilinskiVP, Controller and Treasurer | 23,967 | $25.01 | $599,436 | 1,923 | −92.6% | plan? |
| Feb 28, 2018 MForm 4 → | Mar 1, 5:24 pm EST | Lynn CilinskiVP, Controller and Treasurer | 23,967 | $1.13 | $27,083 | 25,890 | — | plan? |
| Feb 26, 2018 FForm 4 → | Feb 27, 5:49 pm EST | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 11,070 | $23.46 | $259,702 | 18,930 | — | plan? |
| Jan 24, 2018 SForm 4/A → | Jan 26, 4:01 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 3,000 | $22.50 | $67,500 | 9,100 | −24.8% | plan? |
| Jan 24, 2018 MForm 4/A → | Jan 26, 4:01 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 3,000 | $0.94 | $2,820 | 12,100 | — | plan? |
| Jan 24, 2018 SForm 4 → | Jan 25, 5:22 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 3,000 | $22.50 | $67,500 | 9,100 | −24.8% | plan? amended |
| Jan 24, 2018 MForm 4 → | Jan 25, 5:22 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 3,000 | $0.94 | $2,820 | 12,100 | — | plan? amended |
| Jan 17, 2018 MForm 4 → | Jan 18, 5:19 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 2,000 | $0.94 | $1,880 | 9,100 | — | plan? |
| Jan 16, 2018 MForm 4 → | Jan 18, 5:19 pm EST | James KarrelsSVP, CFO and Secretary | 6,516 | $0.94 | $6,125 | 119,847 | — | plan? |
| Jan 16, 2018 SForm 4 → | Jan 18, 5:19 pm EST | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 5,000 | $20.00 | $100,000 | 30,000 | −14.3% | plan? |
| Jan 16, 2018 MForm 4 → | Jan 18, 5:19 pm EST | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 5,000 | $4.70 | $23,500 | 32,524 | — | plan? |
| Dec 29, 2017 MForm 4 → | Jan 3, 2018, 11:59 am EST | James KarrelsSVP, CFO and Secretary | 3,000 | $0.94 | $2,820 | 113,331 | — | plan? |
| Nov 21, 2017 SForm 4 → | Nov 21, 5:15 pm EST | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 5,000 | $20.00 | $100,000 | 30,000 | −14.3% | plan? |
| Nov 21, 2017 MForm 4 → | Nov 21, 5:15 pm EST | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 5,000 | $4.70 | $23,500 | 35,000 | — | plan? |
| Oct 25, 2017 SForm 4 → | Oct 26, 9:37 am EDT | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 10,000 | $20.00 | $200,000 | 30,000 | −25.0% | plan? |
| Oct 25, 2017 MForm 4 → | Oct 26, 9:37 am EDT | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 10,000 | $4.70 | $47,000 | 40,000 | — | plan? |
| Sep 5, 2017 MForm 4 → | Sep 7, 4:54 pm EDT | James KarrelsSVP, CFO and Secretary | 5,000 | $0.94 | $4,700 | 110,331 | — | plan? |
| Sep 5, 2017 MForm 4 → | Sep 7, 4:52 pm EDT | Eric Blasius RisserSr VP & Chief Business Officer | 2,000 | $0.94 | $1,880 | 6,000 | — | plan? |
| Jul 26, 2017 MForm 4 → | Jul 27, 4:47 pm EDT | Ezio BonviniSr VP, Research & CSO | 53,264 | $1.22 | $65,248 | 146,658 | — | plan? |
| Jun 5, 2017 SForm 4 → | Jun 6, 4:04 pm EDT | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 5,000 | $20.00 | $100,000 | 30,000 | −14.3% | plan? |
| Jun 5, 2017 MForm 4 → | Jun 6, 4:04 pm EDT | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 5,000 | $4.70 | $23,500 | 35,000 | — | plan? |
| May 31, 2017 AForm 5 → | Feb 12, 2018, 5:17 pm EST | Jeffrey Stuart PetersActing General Counsel | 270 | $15.05 | $4,064 | 270 | — | plan? |
| Apr 28, 2017 FForm 4 → | May 2, 12:58 pm EDT | Atul SaranSVP & General Counsel | 1,862 | $21.61 | $40,238 | 16,986 | — | plan? |
| Apr 19, 2017 SForm 4 → | Apr 20, 4:15 pm EDT | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 15,000 | $20.00 | $300,000 | 30,000 | −33.3% | plan? |
| Apr 19, 2017 MForm 4 → | Apr 20, 4:15 pm EDT | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 15,000 | $4.70 | $70,500 | 45,000 | — | plan? |
| Jan 25, 2017 MForm 4 → | Jan 26, 4:36 pm EST | James KarrelsSVP, CFO and Secretary | 5,000 | $0.94 | $4,700 | 105,331 | — | plan? |
| Jan 17, 2017 MForm 4 → | Jan 19, 4:40 pm EST | Scott KoenigPresident and CEO, Director | 79,898 | $0.94 | $75,104 | 133,163 | — | plan? |
| Oct 3, 2016 SForm 5 → | Feb 8, 2017, 5:27 pm EST | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 10,000 | $29.34 | $293,400 | 30,000 | −25.0% | plan? |
| Oct 3, 2016 SForm 4/A → | Oct 19, 5:20 pm EDT | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 10,000 | $29.34 | $293,400 | 0 | −100% | plan? |
| Oct 3, 2016 MForm 4/A → | Oct 19, 5:20 pm EDT | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 10,000 | $4.70 | $47,000 | 10,000 | — | plan? |
| Oct 3, 2016 SForm 4 → | Oct 5, 4:49 pm EDT | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 10,000 | $29.34 | $293,400 | 0 | −100% | plan? amended |
| Oct 3, 2016 MForm 4 → | Oct 5, 4:49 pm EDT | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 10,000 | $4.70 | $47,000 | 10,000 | — | plan? amended |
| Oct 3, 2016 SForm 4 → | Oct 5, 4:49 pm EDT | Lynn CilinskiVP, Controller and Treasurer | 6,231 | $29.28 | $182,444 | 1,923 | −76.4% | plan? |
| Oct 3, 2016 MForm 4 → | Oct 5, 4:49 pm EDT | Lynn CilinskiVP, Controller and Treasurer | 6,231 | $0.94 | $5,857 | 8,154 | — | plan? |
| Aug 1, 2016 SForm 4 → | Aug 3, 4:51 pm EDT | Jon Marc WiggintonSr VP Clinical Dev & CMO | 20,000 | $30.78 | $615,600 | 0 | −100% | plan? |
| Aug 1, 2016 MForm 4 → | Aug 3, 4:51 pm EDT | Jon Marc WiggintonSr VP Clinical Dev & CMO | 20,000 | $4.70 | $94,000 | 20,000 | — | plan? |
| Jul 1, 2016 SForm 4 → | Jul 6, 8:44 pm EDT | Jon Marc WiggintonSr VP Clinical Dev & CMO | 5,000 | $27.22 | $136,100 | 0 | −100% | plan? |
| Jul 1, 2016 MForm 4 → | Jul 6, 8:44 pm EDT | Jon Marc WiggintonSr VP Clinical Dev & CMO | 5,000 | $4.70 | $23,500 | 5,000 | — | plan? |
| Jul 1, 2016 SForm 4 → | Jul 6, 8:43 pm EDT | Lynn CilinskiVP, Controller and Treasurer | 8,922 | $27.22 | $242,857 | 1,923 | −82.3% | plan? |
| Jul 1, 2016 MForm 4 → | Jul 6, 8:43 pm EDT | Lynn CilinskiVP, Controller and Treasurer | 8,922 | $0.94 | $8,387 | 10,845 | — | plan? |
| May 27, 2016 SForm 4 → | May 27, 2:32 pm EDT | Lynn CilinskiVP, Controller and Treasurer | 5,000 | $25.00 | $125,000 | 1,923 | −72.2% | plan? |
| May 27, 2016 MForm 4 → | May 27, 2:32 pm EDT | Lynn CilinskiVP, Controller and Treasurer | 5,000 | $0.94 | $4,700 | 6,923 | — | plan? |
| May 17, 2016 JForm 5 → | Jan 19, 2017, 4:40 pm EST | Scott KoenigPresident and CEO, Director | 229,034 | — | — | 167,782 | — | plan? |
| May 16, 2016 MForm 4 → | May 17, 11:55 am EDT | Scott KoenigPresident and CEO, Director | 34,619 | $0.94 | $32,542 | 167,782 | — | plan? |
| May 11, 2016 MForm 4 → | May 13, 10:25 am EDT | Scott KoenigPresident and CEO, Director | 79,898 | $0.94 | $75,104 | 133,163 | — | plan? |
| Apr 28, 2016 FForm 4/A → | Jun 1, 11:01 am EDT | Atul SaranSVP & General Counsel | 1,862 | $20.84 | $38,804 | 18,848 | — | plan? |
| Apr 28, 2016 FForm 4 → | Apr 29, 3:38 pm EDT | Atul SaranSVP & General Counsel | 1,730 | $20.84 | $36,053 | 18,980 | — | plan? amended |
| Mar 3, 2016 PForm 4 → | Mar 4, 8:12 am EST | Paulo F CostaDirector | 10,000 | $17.20 | $172,000 | 59,435 | +20.2% | plan? |
| Feb 25, 2016 AForm 4 → | Feb 29, 12:21 pm EST | Jon Marc WiggintonSr VP, Clinical Dev & CMO | 30,000 | — | — | 30,000 | — | plan? |
| Feb 11, 2016 MForm 4 → | Oct 21, 7:19 pm EDT | Ezio BonviniSr VP, Research & CSO | 17,311 | $0.94 | $16,272 | 100,944 | — | plan? late |
| Feb 8, 2016 MForm 4 → | Feb 10, 8:51 pm EST | Eric Blasius RisserSVP, Business Development | 2,500 | $0.94 | $2,350 | 4,000 | — | plan? |
| Jan 29, 2016 MForm 4 → | Feb 2, 4:42 pm EST | James KarrelsSVP, CFO and Secretary | 10,000 | $0.94 | $9,400 | 100,331 | — | plan? |
| Jan 7, 2016 MForm 4 → | Jan 11, 1:39 pm EST | Kathryn E SteinSVP, Product Dev. & Regulatory | 52,350 | $0.8563 | $44,825 | 95,555 | — | plan? |
| Jan 7, 2016 MForm 4 → | Jan 11, 1:39 pm EST | Ezio BonviniSenior VP, Research | 13,316 | $0.94 | $12,517 | 83,633 | — | plan? |
| Jan 4, 2016 SForm 4 → | Jan 6, 6:51 pm EST | Jon Marc WiggintonSr VP, Clinical | 10,000 | $29.64 | $296,400 | 0 | −100% | plan? |
| Jan 4, 2016 MForm 4 → | Jan 6, 6:51 pm EST | Jon Marc WiggintonSr VP, Clinical | 10,000 | $4.70 | $47,000 | 10,000 | — | plan? |
| Dec 23, 2015 MForm 4 → | Dec 23, 1:26 pm EST | Eric Blasius RisserSVP, Business Development | 1,500 | $0.94 | $1,410 | 1,500 | — | plan? |
| Nov 23, 2015 SForm 4 → | Nov 24, 3:32 pm EST | Lynn CilinskiVP, Controller and Treasurer | 6,921 | $35.00 | $242,235 | 1,923 | −78.3% | plan? |
| Nov 16, 2015 SForm 4 → | Nov 17, 3:22 pm EST | Ezio BonviniSenior VP, Research | 3,117 | $31.44 | $97,998 | 70,317 | −4.24% | plan? |
| Oct 15, 2015 SForm 4 → | Oct 19, 3:01 pm EDT | Ezio BonviniSenior VP, Research | 6,233 | $25.21 | $157,134 | 73,434 | −7.82% | plan? |
| Oct 13, 2015 MForm 4 → | Oct 15, 2:37 pm EDT | Ezio BonviniSenior VP, Research | 29,042 | $13.12 | $381,031 | 79,667 | — | plan? |
| Oct 7, 2015 MForm 4 → | Oct 9, 9:52 am EDT | James KarrelsSVP, CFO and Secretary | 6,000 | $0.94 | $5,640 | 10,100 | — | plan? |
| Oct 2, 2015 MForm 4 → | Oct 6, 2:19 pm EDT | Ezio BonviniSenior VP, Research | 17,877 | $0.94 | $16,804 | 79,667 | — | plan? |
| Oct 1, 2015 SForm 4/A → | Oct 7, 4:08 pm EDT | Jon Marc WiggintonSr VP, Clinical | 5,000 | $21.11 | $105,550 | 0 | −100% | plan? |
| Oct 1, 2015 MForm 4/A → | Oct 7, 4:08 pm EDT | Jon Marc WiggintonSr VP, Clinical | 5,000 | $4.70 | $23,500 | 5,000 | — | plan? |
| Oct 1, 2015 SForm 4 → | Oct 2, 4:22 pm EDT | Jon Marc WiggintonSr VP, Clinical | 5,000 | $21.11 | $105,550 | 0 | −100% | plan? amended |
| Oct 1, 2015 MForm 4 → | Oct 2, 4:22 pm EDT | Jon Marc WiggintonSr VP, Clinical | 5,000 | $4.70 | $23,500 | 5,000 | — | plan? amended |
| Sep 22, 2015 JMForm 5 → | Feb 8, 2017, 5:18 pm EST | Ezio BonviniSr VP, Research & CSO | 12,899 | $0.94 | $5,028 | 7,550 | — | plan? |
| Sep 22, 2015 GForm 5 → | Feb 12, 2016, 4:34 pm EST | Ezio BonviniSenior VP, Research | 7,550 | — | — | 76,083 | — | plan? |
| Sep 18, 2015 MForm 4 → | Sep 22, 3:19 pm EDT | Ezio BonviniSenior VP, Research | 7,000 | $0.94 | $6,580 | 61,790 | — | plan? |
| Sep 16, 2015 MForm 4 → | Sep 18, 10:33 am EDT | Ezio BonviniSenior VP, Research | 4,000 | $0.94 | $3,760 | 54,790 | — | plan? |
| Aug 26, 2015 MForm 4 → | Aug 28, 11:30 am EDT | Ezio BonviniSenior VP, Research | 10,000 | $0.94 | $9,400 | 50,790 | — | plan? |
| Aug 10, 2015 MForm 4 → | Aug 11, 8:41 am EDT | Ezio BonviniSenior VP, Research | 4,000 | $0.94 | $3,760 | 40,790 | — | plan? |
| Aug 3, 2015 SForm 4/A → | Oct 7, 4:07 pm EDT | Jon Marc WiggintonSr VP, Clinical | 10,000 | $37.15 | $371,500 | 0 | −100% | plan? |
| Aug 3, 2015 MForm 4/A → | Oct 7, 4:07 pm EDT | Jon Marc WiggintonSr VP, Clinical | 10,000 | $4.70 | $47,000 | 10,000 | — | plan? |
| Aug 3, 2015 SForm 4 → | Aug 3, 2:47 pm EDT | Jon Marc WiggintonSr VP, Clinical | 10,000 | $37.15 | $371,500 | 0 | −100% | plan? amended |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 MForm 4 → | Aug 18, 4:19 pm EDT | Ezio BonviniSr VP, Research & CSO | 40,000 | $2.60 | $104,000 | 88,000 | — | |
| Feb 21, 2019 AForm 4 → | Feb 25, 4:03 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 85,000 | — | — | 85,000 | — | |
| Feb 21, 2019 AForm 4 → | Feb 25, 4:03 pm EST | Thomas SpitznagelSr VP, BPD & Manufacturing | 70,000 | — | — | 70,000 | — | |
| Feb 21, 2019 AForm 4 → | Feb 25, 4:02 pm EST | James KarrelsSVP, CFO and Secretary | 85,000 | — | — | 85,000 | — | |
| Feb 21, 2019 AForm 4 → | Feb 25, 4:02 pm EST | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 90,000 | — | — | 90,000 | — | |
| Feb 21, 2019 AForm 4 → | Feb 25, 4:01 pm EST | Lynn CilinskiVP, Controller and Treasurer | 35,000 | — | — | 35,000 | — | |
| Feb 21, 2019 AForm 4 → | Feb 25, 4:01 pm EST | Ezio BonviniSr VP, Research & CSO | 90,000 | — | — | 90,000 | — | |
| Feb 21, 2019 AForm 4 → | Feb 25, 4:01 pm EST | Jeffrey Stuart PetersGeneral Counsel | 70,000 | — | — | 70,000 | — | |
| Feb 21, 2019 AForm 4 → | Feb 25, 4:00 pm EST | Scott KoenigPresident and CEO, Director | 260,000 | — | — | 260,000 | — | |
| Feb 6, 2019 MForm 4 → | Feb 8, 5:41 pm EST | Matthew K FustDirector | 6,924 | — | — | 0 | — | |
| Feb 6, 2019 MForm 4 → | Feb 8, 5:40 pm EST | Thomas SpitznagelSr VP, BPD & Manufacturing | 1,770 | — | — | 62,147 | — | |
| Jan 28, 2019 MForm 4 → | Jan 28, 4:12 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 6,000 | — | — | 2,497 | — | |
| Jan 24, 2019 MForm 4 → | Jan 28, 4:10 pm EST | James KarrelsSVP, CFO and Secretary | 7,326 | — | — | 7,320 | — | |
| Jan 8, 2019 MForm 4 → | Jan 10, 3:58 pm EST | James KarrelsSVP, CFO and Secretary | 5,314 | — | — | 0 | — | |
| Jan 3, 2019 MForm 4 → | Jan 4, 4:29 pm EST | Scott KoenigPresident and CEO, Director | 39,897 | — | — | 0 | — | |
| Dec 18, 2018 MForm 4 → | Dec 20, 4:04 pm EST | James KarrelsSVP, CFO and Secretary | 5,000 | — | — | 5,314 | — | |
| Dec 12, 2018 MForm 4 → | Dec 13, 4:39 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 5,000 | — | — | 4,497 | — | |
| Nov 27, 2018 MForm 4 → | Nov 27, 4:44 pm EST | James KarrelsSVP, CFO and Secretary | 3,000 | — | — | 1,420 | — | |
| Nov 13, 2018 MForm 4 → | Nov 14, 4:48 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 4,000 | — | — | 9,497 | — | |
| Nov 13, 2018 MForm 4 → | Nov 14, 4:32 pm EST | Scott KoenigPresident and CEO, Director | 40,000 | — | — | 39,897 | — | |
| Oct 22, 2018 MForm 4 → | Oct 23, 12:32 pm EDT | Eric Blasius RisserSr VP & Chief Business Officer | 3,000 | — | — | 13,497 | — | |
| May 17, 2018 AForm 4 → | May 21, 4:55 pm EDT | Kenneth GalbraithDirector | 10,000 | — | — | 10,000 | — | |
| May 17, 2018 AForm 4 → | May 21, 4:54 pm EDT | Karen Jean FerranteDirector | 10,000 | — | — | 10,000 | — | |
| May 17, 2018 AForm 4 → | May 21, 4:54 pm EDT | Jay Philip SiegelDirector | 10,000 | — | — | 10,000 | — | |
| May 17, 2018 AForm 4 → | May 21, 4:54 pm EDT | Paulo F CostaDirector | 16,293 | — | — | 6,293 | — | |
| May 17, 2018 AForm 4 → | May 21, 4:53 pm EDT | Edward HurwitzDirector | 10,000 | — | — | 10,000 | — | |
| May 17, 2018 AForm 4 → | May 21, 4:53 pm EDT | David C StumpDirector | 10,000 | — | — | 10,000 | — | |
| May 17, 2018 AForm 4 → | May 21, 4:53 pm EDT | Scott Thomas JacksonDirector | 10,000 | — | — | 10,000 | — | |
| May 17, 2018 AForm 4 → | May 21, 4:52 pm EDT | Matthew K FustDirector | 10,000 | — | — | 10,000 | — | |
| Mar 12, 2018 MForm 4 → | Mar 14, 5:12 pm EDT | Eric Blasius RisserSr VP & Chief Business Officer | 1,000 | — | — | 20,497 | — | |
| Mar 2, 2018 AForm 4 → | Mar 6, 5:25 pm EST | James KarrelsSVP, CFO and Secretary | 70,000 | — | — | 70,000 | — | |
| Mar 2, 2018 AForm 4 → | Mar 6, 5:24 pm EST | Jeffrey Stuart PetersActing General Counsel | 50,000 | — | — | 50,000 | — | |
| Mar 2, 2018 AForm 4 → | Mar 6, 5:24 pm EST | Ezio BonviniSr VP, Research & CSO | 70,000 | — | — | 70,000 | — | |
| Mar 2, 2018 AMForm 4 → | Mar 6, 5:24 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 74,000 | — | — | 21,497 | — | |
| Mar 2, 2018 AForm 4 → | Mar 6, 5:23 pm EST | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 70,000 | — | — | 70,000 | — | |
| Mar 2, 2018 AForm 4 → | Mar 6, 5:23 pm EST | Scott KoenigPresident and CEO, Director | 225,000 | — | — | 225,000 | — | |
| Mar 2, 2018 AForm 4 → | Mar 6, 5:23 pm EST | Thomas SpitznagelSr VP, BPD & Manufacturing | 50,000 | — | — | 50,000 | — | |
| Mar 2, 2018 AForm 4 → | Mar 6, 5:22 pm EST | Lynn CilinskiVP, Controller and Treasurer | 28,000 | — | — | 28,000 | — | |
| Feb 28, 2018 MForm 4 → | Mar 1, 5:24 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 1,000 | — | — | 25,497 | — | |
| Feb 28, 2018 MForm 4 → | Mar 1, 5:24 pm EST | Lynn CilinskiVP, Controller and Treasurer | 23,967 | — | — | 0 | — | |
| Jan 24, 2018 MForm 4/A → | Jan 26, 4:01 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 3,000 | — | — | 26,497 | — | |
| Jan 24, 2018 MForm 4 → | Jan 25, 5:22 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 3,000 | — | — | 26,497 | — | amended |
| Jan 17, 2018 MForm 4 → | Jan 18, 5:19 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 2,000 | — | — | 29,497 | — | |
| Jan 16, 2018 MForm 4 → | Jan 18, 5:19 pm EST | James KarrelsSVP, CFO and Secretary | 6,516 | — | — | 0 | — | |
| Jan 16, 2018 MForm 4 → | Jan 18, 5:19 pm EST | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 5,000 | — | — | 45,448 | — | |
| Dec 29, 2017 MForm 4 → | Jan 3, 2018, 11:59 am EST | James KarrelsSVP, CFO and Secretary | 3,000 | — | — | 6,516 | — | |
| Nov 21, 2017 MForm 4 → | Nov 21, 5:15 pm EST | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 5,000 | — | — | 50,448 | — | |
| Nov 13, 2017 AForm 4 → | Nov 15, 6:21 pm EST | Jay Philip SiegelDirector | 20,000 | — | — | 20,000 | — | |
| Oct 25, 2017 MForm 4 → | Oct 26, 9:37 am EDT | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 10,000 | $4.70 | $47,000 | 55,448 | — | |
| Sep 5, 2017 MForm 4 → | Sep 7, 4:54 pm EDT | James KarrelsSVP, CFO and Secretary | 5,000 | — | — | 9,516 | — | |
| Sep 5, 2017 MForm 4 → | Sep 7, 4:52 pm EDT | Eric Blasius RisserSr VP & Chief Business Officer | 2,000 | — | — | 31,497 | — | |
| Jul 26, 2017 MForm 4 → | Jul 27, 4:47 pm EDT | Ezio BonviniSr VP, Research & CSO | 53,264 | $1.22 | $65,248 | 0 | — | |
| Jun 5, 2017 MForm 4 → | Jun 6, 4:04 pm EDT | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 5,000 | $4.70 | $23,500 | 65,448 | — | |
| May 18, 2017 AForm 4 → | May 22, 7:02 pm EDT | Scott Thomas JacksonDirector | 10,000 | — | — | 10,000 | — | |
| May 18, 2017 AForm 4 → | May 22, 7:02 pm EDT | David C StumpDirector | 10,000 | — | — | 10,000 | — | |
| May 18, 2017 AForm 4 → | May 22, 7:02 pm EDT | Kenneth GalbraithDirector | 10,000 | — | — | 10,000 | — | |
| May 18, 2017 AForm 4 → | May 22, 7:02 pm EDT | Karen Jean FerranteDirector | 10,000 | — | — | 10,000 | — | |
| May 18, 2017 AForm 4 → | May 22, 7:01 pm EDT | Edward HurwitzDirector | 10,000 | — | — | 10,000 | — | |
| May 18, 2017 AForm 4 → | May 22, 7:01 pm EDT | Paulo F CostaDirector | 16,057 | — | — | 6,057 | — | |
| May 18, 2017 AForm 4 → | May 22, 7:01 pm EDT | Matthew K FustDirector | 10,000 | — | — | 10,000 | — | |
| Apr 19, 2017 MForm 4 → | Apr 20, 4:15 pm EDT | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 15,000 | — | — | 70,448 | — | |
| Feb 15, 2017 AForm 4 → | Feb 16, 5:46 pm EST | Lynn CilinskiVP, Controller and Treasurer | 28,000 | $20.53 | $574,840 | 28,000 | — | |
| Feb 15, 2017 AForm 4 → | Feb 16, 5:46 pm EST | James KarrelsSVP, CFO and Secretary | 55,000 | $20.53 | $1,129,150 | 55,000 | — | |
| Feb 15, 2017 AForm 4 → | Feb 16, 5:45 pm EST | Atul SaranSVP & General Counsel | 55,000 | $20.53 | $1,129,150 | 55,000 | — | |
| Feb 15, 2017 AForm 4 → | Feb 16, 5:45 pm EST | Thomas SpitznagelSr VP, BPD & Manufacturing | 45,000 | $20.53 | $923,850 | 45,000 | — | |
| Feb 15, 2017 AForm 4 → | Feb 16, 5:45 pm EST | Eric Blasius RisserSr VP & Chief Business Officer | 55,000 | $20.53 | $1,129,150 | 55,000 | — | |
| Feb 15, 2017 AForm 4 → | Feb 16, 5:45 pm EST | Ezio BonviniSr VP, Research & CSO | 67,500 | $20.53 | $1,385,775 | 67,500 | — | |
| Feb 15, 2017 AForm 4 → | Feb 16, 5:44 pm EST | Scott KoenigPresident and CEO, Director | 200,000 | — | — | 200,000 | — | |
| Feb 15, 2017 AForm 4 → | Feb 16, 5:44 pm EST | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 67,500 | $20.53 | $1,385,775 | 67,500 | — | |
| Jan 25, 2017 MForm 4 → | Jan 26, 4:36 pm EST | James KarrelsSVP, CFO and Secretary | 5,000 | — | — | 14,516 | — | |
| Jan 24, 2017 AForm 4 → | Jan 25, 5:58 pm EST | Karen Jean FerranteDirector | 20,000 | — | — | 20,000 | — | |
| Jan 24, 2017 AForm 4 → | Jan 25, 5:56 pm EST | Scott Thomas JacksonDirector | 20,000 | — | — | 20,000 | — | |
| Jan 17, 2017 MForm 4 → | Jan 19, 4:40 pm EST | Scott KoenigPresident and CEO, Director | 79,898 | $0.94 | $75,104 | 0 | — | |
| Oct 3, 2016 MForm 4/A → | Oct 19, 5:20 pm EDT | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 10,000 | — | — | 25,254 | — | |
| Oct 3, 2016 MForm 4 → | Oct 5, 4:49 pm EDT | Jon Marc WiggintonSr VP, Clinical Dev. & CMO | 10,000 | — | — | 15,254 | — | amended |
| Oct 3, 2016 MForm 4 → | Oct 5, 4:49 pm EDT | Lynn CilinskiVP, Controller and Treasurer | 6,231 | — | — | 0 | — | |
| Sep 14, 2016 AForm 4 → | Sep 16, 6:12 pm EDT | Thomas SpitznagelSr VP, BPD & Manufacturing | 20,000 | — | — | 20,000 | — | |
| Sep 14, 2016 AForm 4 → | Sep 16, 6:11 pm EDT | Eric Blasius RisserSr VP & Chief Business Officer | 25,000 | — | — | 25,000 | — | |
| Sep 14, 2016 AForm 4 → | Sep 16, 6:10 pm EDT | Ezio BonviniSr VP, Research & CSO | 30,000 | — | — | 30,000 | — | |
| Aug 1, 2016 MForm 4 → | Aug 3, 4:51 pm EDT | Jon Marc WiggintonSr VP Clinical Dev & CMO | 20,000 | — | — | 35,254 | — | |
| Jul 1, 2016 MForm 4 → | Jul 6, 8:44 pm EDT | Jon Marc WiggintonSr VP Clinical Dev & CMO | 5,000 | — | — | 55,254 | — | |
| Jul 1, 2016 MForm 4 → | Jul 6, 8:43 pm EDT | Lynn CilinskiVP, Controller and Treasurer | 8,922 | — | — | 7,989 | — | |
| May 27, 2016 MForm 4 → | May 27, 2:32 pm EDT | Lynn CilinskiVP, Controller and Treasurer | 5,000 | — | — | 4,501 | — | |
| May 18, 2016 AForm 4 → | May 20, 9:22 am EDT | Kenneth GalbraithDirector | 8,500 | — | — | 8,500 | — | |
| May 18, 2016 AForm 4 → | May 20, 9:18 am EDT | Edward HurwitzDirector | 8,500 | — | — | 8,500 | — | |
| May 18, 2016 AForm 4 → | May 20, 9:17 am EDT | David C StumpDirector | 8,500 | — | — | 8,500 | — | |
| May 18, 2016 AForm 4 → | May 20, 9:15 am EDT | Matthew K FustDirector | 8,500 | — | — | 8,500 | — | |
| May 18, 2016 AForm 4 → | May 20, 9:14 am EDT | Paulo F CostaDirector | 14,174 | — | — | 5,674 | — | |
| May 16, 2016 MForm 4 → | May 17, 11:55 am EDT | Scott KoenigPresident and CEO, Director | 34,619 | — | — | 79,897 | — | |
| May 11, 2016 MForm 4 → | May 13, 10:25 am EDT | Scott KoenigPresident and CEO, Director | 79,898 | — | — | 79,898 | — | |
| Feb 11, 2016 MForm 4 → | Oct 21, 7:19 pm EDT | Ezio BonviniSr VP, Research & CSO | 17,311 | — | — | 0 | — | late |
| Feb 8, 2016 MForm 4 → | Feb 10, 8:51 pm EST | Eric Blasius RisserSVP, Business Development | 2,500 | — | — | 3,836 | — | |
| Jan 29, 2016 DForm 4 → | Feb 2, 4:42 pm EST | James KarrelsSVP, CFO and Secretary | 10,000 | — | — | 19,516 | — | |
| Jan 7, 2016 MForm 4 → | Jan 11, 1:39 pm EST | Kathryn E SteinSVP, Product Dev. & Regulatory | 52,350 | — | — | 0 | — | |
| Jan 7, 2016 MForm 4 → | Jan 11, 1:39 pm EST | Ezio BonviniSenior VP, Research | 13,316 | — | — | 0 | — | |
| Jan 4, 2016 MForm 4 → | Jan 6, 6:51 pm EST | Jon Marc WiggintonSr VP, Clinical | 10,000 | — | — | 60,254 | — | |
| Dec 23, 2015 MForm 4 → | Dec 23, 1:26 pm EST | Eric Blasius RisserSVP, Business Development | 1,500 | — | — | 14,336 | — | |
| Dec 18, 2015 AForm 4 → | Dec 22, 1:15 pm EST | Jon Marc WiggintonSr VP, Clinical | 55,000 | — | — | 55,000 | — | |
| Dec 18, 2015 AForm 4 → | Dec 22, 1:15 pm EST | Atul SaranSr. VP and General Counsel | 45,000 | — | — | 45,000 | — | |
| Dec 18, 2015 AForm 4 → | Dec 22, 1:14 pm EST | Eric Blasius RisserSVP, Business Development | 45,000 | — | — | 45,000 | — |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.